rs115552500

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000096.4(CP):​c.2378G>A​(p.Arg793His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00991 in 1,611,260 control chromosomes in the GnomAD database, including 104 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R793C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.012 ( 16 hom., cov: 31)
Exomes 𝑓: 0.0097 ( 88 hom. )

Consequence

CP
NM_000096.4 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.42

Publications

19 publications found
Variant links:
Genes affected
CP (HGNC:2295): (ceruloplasmin) The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]
CP Gene-Disease associations (from GenCC):
  • aceruloplasminemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • disorder of iron metabolism and transport
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006608665).
BP6
Variant 3-149183513-C-T is Benign according to our data. Variant chr3-149183513-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 128839.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0118 (1796/151754) while in subpopulation AFR AF = 0.0194 (802/41354). AF 95% confidence interval is 0.0183. There are 16 homozygotes in GnomAd4. There are 866 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 16 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CPNM_000096.4 linkc.2378G>A p.Arg793His missense_variant Exon 13 of 19 ENST00000264613.11 NP_000087.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CPENST00000264613.11 linkc.2378G>A p.Arg793His missense_variant Exon 13 of 19 1 NM_000096.4 ENSP00000264613.6
CPENST00000494544.1 linkc.1727G>A p.Arg576His missense_variant Exon 10 of 16 1 ENSP00000420545.1
CPENST00000490639.5 linkn.2410G>A non_coding_transcript_exon_variant Exon 13 of 17 1
CPENST00000481169.5 linkn.2165G>A non_coding_transcript_exon_variant Exon 12 of 18 2 ENSP00000418773.1

Frequencies

GnomAD3 genomes
AF:
0.0118
AC:
1794
AN:
151636
Hom.:
16
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0194
Gnomad AMI
AF:
0.0384
Gnomad AMR
AF:
0.0121
Gnomad ASJ
AF:
0.00663
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.000768
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0102
Gnomad OTH
AF:
0.0163
GnomAD2 exomes
AF:
0.00731
AC:
1838
AN:
251338
AF XY:
0.00710
show subpopulations
Gnomad AFR exome
AF:
0.0202
Gnomad AMR exome
AF:
0.00746
Gnomad ASJ exome
AF:
0.00595
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000741
Gnomad NFE exome
AF:
0.00883
Gnomad OTH exome
AF:
0.0116
GnomAD4 exome
AF:
0.00971
AC:
14175
AN:
1459506
Hom.:
88
Cov.:
31
AF XY:
0.00953
AC XY:
6922
AN XY:
726084
show subpopulations
African (AFR)
AF:
0.0178
AC:
595
AN:
33412
American (AMR)
AF:
0.00756
AC:
338
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00574
AC:
150
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39644
South Asian (SAS)
AF:
0.00312
AC:
269
AN:
86154
European-Finnish (FIN)
AF:
0.00152
AC:
81
AN:
53240
Middle Eastern (MID)
AF:
0.0134
AC:
60
AN:
4462
European-Non Finnish (NFE)
AF:
0.0109
AC:
12060
AN:
1111522
Other (OTH)
AF:
0.0103
AC:
621
AN:
60224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
655
1310
1964
2619
3274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
474
948
1422
1896
2370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0118
AC:
1796
AN:
151754
Hom.:
16
Cov.:
31
AF XY:
0.0117
AC XY:
866
AN XY:
74108
show subpopulations
African (AFR)
AF:
0.0194
AC:
802
AN:
41354
American (AMR)
AF:
0.0121
AC:
184
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00663
AC:
23
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.00291
AC:
14
AN:
4818
European-Finnish (FIN)
AF:
0.000768
AC:
8
AN:
10416
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0102
AC:
690
AN:
67968
Other (OTH)
AF:
0.0161
AC:
34
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
92
184
277
369
461
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00980
Hom.:
15
Bravo
AF:
0.0124
TwinsUK
AF:
0.0140
AC:
52
ALSPAC
AF:
0.00908
AC:
35
ESP6500AA
AF:
0.0202
AC:
89
ESP6500EA
AF:
0.00919
AC:
79
ExAC
AF:
0.00708
AC:
860
Asia WGS
AF:
0.00144
AC:
6
AN:
3478
EpiCase
AF:
0.0108
EpiControl
AF:
0.0106

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 04, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Deficiency of ferroxidase Benign:3
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.

Jan 04, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 30, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 15557511, 25758665, 26000822, 16150804)

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

CP-related disorder Benign:1
Mar 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
14
DANN
Benign
0.97
DEOGEN2
Benign
0.0
.;T
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.040
N
LIST_S2
Benign
0.0
.;D
MetaRNN
Benign
0.0066
T;T
MetaSVM
Uncertain
0.46
D
MutationAssessor
Benign
0.0
.;.
PhyloP100
-1.4
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-1.9
N;N
REVEL
Uncertain
0.34
Sift
Benign
0.12
T;T
Sift4G
Benign
0.12
T;T
Vest4
0.15
ClinPred
0.012
T
GERP RS
-1.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.50
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115552500; hg19: chr3-148901300; COSMIC: COSV52829268; COSMIC: COSV52829268; API